132 related articles for article (PubMed ID: 20005410)
1. Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.
Marfo K; Chapochnick-Friedmann J; Akalin E; Lu A
Transplant Proc; 2009 Dec; 41(10):4411-3. PubMed ID: 20005410
[TBL] [Abstract][Full Text] [Related]
2. Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction.
Kute V; Goplani KR; Godara SM; Shah PR; Vanikar AV; Trivedii HL
J Assoc Physicians India; 2011 Jan; 59():49-51. PubMed ID: 21751666
[TBL] [Abstract][Full Text] [Related]
3. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
[TBL] [Abstract][Full Text] [Related]
4. Swine H1N1 infection in a renal transplant recipient.
Ozkan G; Ulusoy S; Kaynar K; Oztuna F; Cansiz M; Kazaz N
Exp Clin Transplant; 2010 Dec; 8(4):318-20. PubMed ID: 21143099
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of solid organs procured from influenza A H1N1 infected donors.
Cockbain AJ; Jacob M; Ecuyer C; Hostert L; Ahmad N
Transpl Int; 2011 Dec; 24(12):e107-10. PubMed ID: 21954984
[TBL] [Abstract][Full Text] [Related]
6. Do immunosupressive patients really have a severe outcome with H1N1 virus infection?
Akyüz S; Yilmaz A; Bülbül M; Erdogan O; Renda R; Demircin G
J Trop Pediatr; 2011 Apr; 57(2):129-31. PubMed ID: 20587734
[TBL] [Abstract][Full Text] [Related]
7. Pandemic influenza A/H1N1 and organ donation.
Lattes R; Jacob N; de la Fuente J; Fragale G; Massari P
Transpl Infect Dis; 2010 Apr; 12(2):169-72. PubMed ID: 20180928
[TBL] [Abstract][Full Text] [Related]
8. Swine H1N1 influenza in a post liver transplant patient.
Jurawan R; de Almeida M; Smith A; Weilert F
N Z Med J; 2009 Oct; 122(1304):107-11. PubMed ID: 19859096
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
Rohn A; Kessler HH; Valentin T; Linkesch W; Neumeister P
Bone Marrow Transplant; 2011 Feb; 46(2):312-3. PubMed ID: 20436526
[No Abstract] [Full Text] [Related]
12. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
[No Abstract] [Full Text] [Related]
14. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
15. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
[TBL] [Abstract][Full Text] [Related]
16. H1N1 in dialysis units: prevention and management.
Karkar A; Abdelrahman M; Jasim MR; AlOyouni W
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):715-9. PubMed ID: 20587878
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
18. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(18):497-500. PubMed ID: 19444154
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
